Found: 7
Select item for more details and to access through your institution.
Fabrication and Modelling of a Reservoir-Based Drug Delivery System for Customizable Release.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 4, p. N.PAG, doi. 10.3390/pharmaceutics14040777
- By:
- Publication type:
- Article
Sequential Treatment with Temozolomide Plus Naturally Derived AT101 as an Alternative Therapeutic Strategy: Insights into Chemoresistance Mechanisms of Surviving Glioblastoma Cells.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 10, p. 9075, doi. 10.3390/ijms24109075
- By:
- Publication type:
- Article
Effects of the Anti-Tumorigenic Agent AT101 on Human Glioblastoma Cells in the Microenvironmental Glioma Stem Cell Niche.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 7, p. 3606, doi. 10.3390/ijms22073606
- By:
- Publication type:
- Article
Localized Drug Delivery Systems in High‐Grade Glioma Therapy—From Construction to Application.
- Published in:
- Advanced Therapeutics, 2022, v. 5, n. 8, p. 1, doi. 10.1002/adtp.202200013
- By:
- Publication type:
- Article
Temporal and regional expression changes and co‐staining patterns of metabolic and stemness‐related markers during glioblastoma progression.
- Published in:
- European Journal of Neuroscience, 2024, v. 60, n. 1, p. 3572, doi. 10.1111/ejn.16357
- By:
- Publication type:
- Article
Establishment of a Rodent Glioblastoma Partial Resection Model for Chemotherapy by Local Drug Carriers—Sharing Experience.
- Published in:
- Biomedicines, 2023, v. 11, n. 6, p. 1518, doi. 10.3390/biomedicines11061518
- By:
- Publication type:
- Article
Insights into Gene Regulation under Temozolomide-Promoted Cellular Dormancy and Its Connection to Stemness in Human Glioblastoma.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 11, p. 1491, doi. 10.3390/cells12111491
- By:
- Publication type:
- Article